Effects of VEGFR-3 phosphorylation inhibitor on lymph node metastasis in an orthotopic diffuse-type gastric carcinoma model

British Journal of Cancer

Volumn 101, Issue 7, 2009, Pages 1100-1106

  Yashiro, M ^a   Shinto, O ^a   Nakamura, K ^a   Tendo, M ^a   Matsuoka, T ^a   Matsuzaki, T ^a   Kaizaki, R ^a   Ohira, M ^a   Miwa, A ^b   Hirakawa, K ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KYOWA HAKKO KOGYO CO LTD   (Japan)

Author keywords

Diffuse type gastric carcinoma; Lymph node metastasis; Orthotopic gastric cancer model; Phosphorylation inhibitor; Vascular endothelial cell growth factor receptor 3

Indexed keywords

KI 23057; UNCLASSIFIED DRUG; VASCULOTROPIN INHIBITOR; VASCULOTROPIN RECEPTOR 3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOPHOSPHORYLATION; CANCER CELL; CANCER MODEL; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; IC 50; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; LYMPH VESSEL ENDOTHELIUM; LYMPHANGIOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; STOMACH CANCER; STOMACH CARCINOMA; TUMOR VOLUME;

ANIMALS; CELL LINE, TUMOR; FEMALE; GLYCOPROTEINS; HUMANS; LYMPHANGIOGENESIS; LYMPHATIC METASTASIS; MICE; MICE, INBRED BALB C; PHOSPHORYLATION; QUINOLINES; STOMACH NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR C; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-3;

EID: 70349670770     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6605296     Document Type: Article

References (25)

1. Amioka T, Kitadai Y, Tanaka S, Haruma K, Yoshihara M, Yasui W, Chayama K (2002) Vascular endothelial growth factor-C expression predicts lymph node metastasis of human gastric carcinomas invading the submucosa. Eur J Cancer 38: 1413-1419 (Pubitemid 34686854)
2. Clarijs R, Ruiter DJ, de Waal RM (2001) Lymphangiogenesis in malignant tumours: does it occur? J Pathol 193: 143-146
3. Fujihara T, Sawada T, Hirakawa K, Chung YS, Yashiro M, Inoue T, Sowa M (1998) Establishment of lymph node metastatic model for human gastric cancer in nude mice and analysis of factors associated with metastasis. Clin Exp Metastasis 16: 389-398 (Pubitemid 28255534)
4. Fujihara T, Yashiro M, Inoue T, Sawada T, Kato Y, Ohira M, Nishiguchi Y, Ishikawa T, Sowa M, Chung KH (1999) Decrease in ICAM-1 expression on gastric cancer cells is correlated with lymph node metastasis. Gastric Cancer 2: 221-225
5. Gombos Z, Xu X, Chu CS, Zhang PJ, Acs G (2005) Peritumoral lymphatic vessel density and vascular endothelial growth factor C expression in early-stage squamous cell carcinoma of the uterine cervix. Clin Cancer Res 11: 8364-8371 (Pubitemid 41746949)
6. Hippo Y, Yashiro M, Ishii M, Taniguchi H, Tsutsumi S, Hirakawa K, Kodama T, Aburatani H (2001) Differential gene expression profiles of scirrhous gastric cancer cells with high metastatic potential to peritoneum or lymph nodes. Cancer Res 61: 889-895 (Pubitemid 32174397)
7. Juttner S, Wissmann C, Jons T, Vieth M, Hertel J, Gretschel S, Schlag PM, Kemmner W, Hocker M (2006) Vascular endothelial growth factor-D and its receptor VEGFR-3: two novel independent prognostic markers in gastric adenocarcinoma. J Clin Oncol 24: 228-240 (Pubitemid 46622052)
8. Karkkainen MJ, Haiko P, Sainio K, Partanen J, Taipale J, Petrova TV, Jeltsch M, Jackson DG, Talikka M, Rauvala H, Betsholtz C, Alitalo K (2004) Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat Immunol 5: 74-80 (Pubitemid 38081471)
9. Kitadai Y, Kodama M, Cho S, Kuroda T, Ochiumi T, Kimura S, Tanaka S, Matsumura S, Yasui W, Chayama K (2005) Quantitative analysis of lymphangiogenic markers for predicting metastasis of human gastric carcinoma to lymph nodes. Int J Cancer 115: 388-392 (Pubitemid 40663742)
10. Kunisaki C, Shimada H, Nomura M, Matsuda G, Otsuka Y, Ono H, Akiyama H (2005) Therapeutic strategy for scirrhous type gastric cancer. Hepatogastroenterology 52: 314-318 (Pubitemid 40282694)
11. Nakamura K, Yamamoto A, Kamishohara M, Takahashi K, Taguchi E, Miura T, Kubo K, Shibuya M, Isoe T (2004) KRN633: a selective inhibitor of vascular endothelial growth factor receptor-2 tyrosine kinase that suppresses tumor angiogenesis and growth. Mol Cancer Ther 3: 1639-1649 (Pubitemid 40136720)
12. Nakamura K, Yashiro M, Matsuoka T, Tendo M, Shimizu T, Miwa A, Hirakawa K (2006) A novel molecular targeting compound as K-samII/ FGF-R2 phosphorylation inhibitor, Ki23057, for scirrhous gastric cancer. Gastroenterology 131: 1530-1541 (Pubitemid 44708935)
13. Nakazawa K, Yashiro M, Hirakawa K (2003) Keratinocyte growth factor produced by gastric fibroblasts specifically stimulates proliferation of cancer cells from scirrhous gastric carcinoma. Cancer Res 63: 8848-8852 (Pubitemid 38064064)
14. Otsuji E, Kuriu Y, Okamoto K, Ochiai T, Ichikawa D, Hagiwara A, Yamagishi H (2004) Outcome of surgical treatment for patients with scirrhous carcinoma of the stomach. Am J Surg 188: 327-332 (Pubitemid 39278295)
15. Shida A, Fujioka S, Kobayashi K, Ishibashi Y, Nimura H, Mitsumori N, Yanaga K (2006) Expression of vascular endothelial growth factor (VEGF)-C and -D in gastric carcinoma. Int J Clin Oncol 11: 38-43 (Pubitemid 43320325)
16. Shimizu T, Fujiwara Y, Osawa T, Sakai T, Kubo K, Nishitoba T, Kimura K, Senga T, Murooka H, Iwai A, Fukushima K, Yoshino T, Miwa A (2004) Orally active anti-proliferation agents: novel diphenylamine derivatives as FGF-R2 autophosphorylation inhibitors. Bioorg Med Chem Lett 14: 875-879 (Pubitemid 38167606)
17. Stacker SA, Achen MG, Jussila L, Baldwin ME, Alitalo K (2002a) Lymphangiogenesis and cancer metastasis. Nat Rev Cancer 2: 573-583
18. Stacker SA, Baldwin ME, Achen MG (2002b) The role of tumor lymphangiogenesis in metastatic spread. FASEB J 16: 922-934
19. Takahashi Y, Cleary KR, Mai M, Kitadai Y, Bucana CD, Ellis LM (1996) Significance of vessel count and vascular endothelial growth factor and its receptor (KDR) in intestinal-type gastric cancer. Clin Cancer Res 2: 1679-1684 (Pubitemid 26356351)
20. Takemura S, Yashiro M, Sunami T, Tendo M, Hirakawa K (2004) Novel models for human scirrhous gastric carcinoma in vivo. Cancer Sci 95: 893-900 (Pubitemid 40045524)
21. Tendo M, Yashiro M, Nakazawa K, Yamada N, Hirakawa K (2005) Inhibitory effect of a selective cyclooxygenase inhibitor on the invasion-stimulating activity of orthotopic fibroblasts for scirrhous gastric cancer cells. Cancer Sci 96: 451-455 (Pubitemid 41179747)
22. Yamaguchi K, Ura H, Yasoshima T, Shishido T, Denno R, Hirata K (2000) Establishment and characterization of a human gastric carcinoma cell line that is highly metastatic to lymph nodes. J Exp Clin Cancer Res 19: 113-120 (Pubitemid 30305529)
23. Yashiro M, Chung YS, Kubo T, Hato F, Sowa M (1996) Differential responses of scirrhous and well-differentiated gastric cancer cells to orthotopic fibroblasts. Br J Cancer 74: 1096-1103 (Pubitemid 26333913)
24. Yashiro M, Sunami T, Hirakawa K (2005) CD54 expression is predictive for lymphatic spread in human gastric carcinoma. Dig Dis Sci 50: 2224-2230 (Pubitemid 43106372)
25. Yonemura Y, Endo Y, Takino T, Sakamoto K, Bandou E, Kinoshita K, Fushida S, Miwa K, Sugiyama K, Sasaki T (2000) Membrane-type 1 matrix metalloproteinase enhances lymph node metastasis of gastric cancer. Clin Exp Metastasis 18: 321-327 (Pubitemid 32579401)